Data / Medical devices / United States / UPS Supply Chain Solutions, Inc.
UPS Supply Chain Solutions, Inc.: FDA-registered device maker in Mira Loma, CA, United States, 42 510(k) clearances
UPS Supply Chain Solutions, Inc. is registered with the FDA (registration 3009637528) in Mira Loma, CA, United States. It lists 15 device types. The FDA files 42 510(k) clearances under its listings, the newest dated February 11, 2019. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3009637528
- Address
- 11811 Landon Drive Suite 100, Mira Loma, CA, United States, 91752
- Owner or operator
- UPS Supply Chain Solutions, Inc. (10038314)
- Roles
- Repackager or relabeler
- First device listed
- January 13, 2020
- Registered through
- 2026
- Brand names listed
- BACT/ALERT® AST, BACT/ALERT® BPA, BACT/ALERT® BPN, BACT/ALERT® FA PLUS, BACT/ALERT® FN PLUS, BACT/ALERT® I FA PLUS, BACT/ALERT® NST, BACT/ALERT® PF PLUS and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| February 11, 2019 | K183166 | BacT/ALERT FA Plus; BacT/ALERT PF Plus | MDB | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| December 8, 2017 | K172731 | VITEK 2 AST-GN Amikacin (<=1 ->=64 ug/mL) | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| July 22, 2017 | K162950 | VITEK MS | PEX | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| June 21, 2017 | K162737 | VITEK 2 AST-GN Ciprofloxacin (<=0.06->=4µg/mL) | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| April 27, 2017 | K162385 | RAPIDEC CARBA NP | PTJ | Substantially Equivalent | Biomerieux S.A. | accessdata.fda.gov |
| March 13, 2017 | K163563 | VITEK 2 AST-GN Gentamicin (<=1 >=16 µg/mL) | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| February 13, 2017 | K161510 | VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| February 1, 2017 | K163083 | VITEK 2 AST-GN Tobramycin (</=1->/= 16 ug/mL); VITEK 2 AST-Gram Negative Tobramycin (</=1->/=16 ug/mL) | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| January 24, 2017 | K163006 | VITEK 2 AST-GN Tigecycline (<0.5->8 ug/mL) | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| June 20, 2014 | K141149 | VITEK 2 AST GP CEFTAROLINE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| January 25, 2013 | K121455 | BACT/ALERT FN PLUS CULTURE BOTTLE | MDB | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| January 25, 2013 | K121446 | BACT/ALERT PF PLUS CULTURE BOTTLE | MDB | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| January 22, 2013 | K121461 | BACT/ALERT FA PLUS CULTURE BOTTLE | MDB | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| October 15, 2012 | K122547 | GRAM POSTITVE CLINDAMYCIN | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| August 7, 2012 | K113783 | VITEK 2 AST- GRAM POSTIVE PENICILLIN FOR STREPTOCOCCUS PNEUMONIAE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| June 29, 2012 | K113200 | VITEK 2 AST-GN PIPERACILLIN/TAZOBACTAM | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| November 30, 2011 | K110106 | VITEK 2 GRAM NEGATIVE TRIMETHOPRIM/SULFAMETHOAZOLE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| October 14, 2011 | K103752 | VITEK 2 SYSTEMS (PC) 5.02 SOFTWARE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| October 21, 2010 | K093076 | VITEK 2 GRAM POSITIVE DOXCYCLINE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| August 14, 2009 | K091899 | VITEK 2 GRAM NEGATIVE MEROPENEM | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| June 18, 2009 | K091126 | VITEK 2 GRAM POSITIVE DAPTOMYCIN | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| February 18, 2009 | K083383 | VITEK 2 GRAM POSITIVE ERYTHROMYCIN FOR STREPTOCOCCUS PNEUMONIAE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| April 30, 2008 | K080201 | VITEK 2 GRAM POSITIVE INDUCIBLE CLINDAMYCIN RESISTANCE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| December 10, 2007 | K073083 | VITEK 2 GRAM NEGATIVE PIPERACILLIN | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| November 16, 2007 | K072695 | VITEK 2 GRAM POSITIVE TIGECYCLINE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| October 15, 2007 | K072668 | VITEK 2 GRAM POSITIVE VANCOMYCIN | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| September 12, 2007 | K072038 | VITEK 2 GRAM NEGATIVE LEVOFLOXACIN | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| January 19, 2007 | K063597 | VITEK 2 GRAM POSITIVE AMOXICILLIN FOR STREPTOCOCCUS PNEUMONIAE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| January 11, 2007 | K063623 | VITEK 2 GRAM POSITIVE MEROPENEM FOR STREPTOCOCCUS PNEUMONIAE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| December 14, 2005 | K053097 | VITEK 2 GRAM POSITIVE CEFOXITIN SCREEN | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| December 1, 2005 | K053186 | VITEK 2 GRAM POSITIVE TELITHROMYCIN FOR STREPTOCOCCUS PNEUMONIAE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| August 16, 2005 | K051849 | VITEK 2 GRAM POSITIVE ERTAPENEM FOR STREPTOCOCCUS PNEUMONIAE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| May 23, 2005 | K050976 | VITEK 2 GRAM POSITIVE TRIMETHOPRIM/SULFAMETHOXAZOLE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| September 14, 2004 | K041982 | VITEK 2 GRAM NEGATIVE ERTAPENEM | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| June 8, 2004 | K040845 | VITEK 2 ESBL TEST | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| October 31, 2003 | K032766 | VITEK 2 GRAM POSITIVE LINEZOLID | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| October 31, 2003 | K032738 | VITEK 2 GRAM POSITIVE QUINUPRISTIN/DALFOPRISTIN | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| September 10, 2003 | K032399 | VITEK 2 GRAM POSITIVE MOXIFLOXACIN | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| August 13, 2003 | K031865 | VITEK 2 GRAM POSITIVE MOXIFLOXACIN FOR STREPOCOCCUS PNEUMONIAE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| July 10, 2003 | K031410 | VITEK 2 GRAM POSITIVE LINEZOLID FOR STREPTOCOCCUS PNEUMONIAE | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| March 29, 2002 | K020871 | VITEK 2 ANTIMIRCROBIAL SUSCEPTIBILITY TEST SYSTEM FOR LEVOFLOXACIN | LON | Substantially Equivalent | bioMerieux, Inc. | accessdata.fda.gov |
| April 29, 1988 | K880961 | ALCON SURGICAL PROCEDURE PACKS | LRO | Substantially Equivalent | Alcon Laboratories | accessdata.fda.gov |
Compare with other makers
- All makers of System, Test, Automated, Antimicrobial Susceptibility, Short Incubation
- All makers of Enzyme Linked Immunoabsorbent Assay, Mumps Virus
- All makers of System, Blood Culturing
- All makers of Panels, Test, Susceptibility, Antimicrobial
- All makers of Susceptibility Test Cards, Antimicrobial
Updated February 11, 2019. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.